Salk T32 Cancer Symposium 2021
Cancer Metabolism

Program

Salk Institute for Biological Studies - Salk T32 Cancer Symposium 2021
Cancer Metabolism - Program

Program


Salk T32 Cancer Symposium 2021 Program

*All times listed are Pacific Standard Time

Zoom meeting link: https://salk-edu.zoom.us/j/85719807271?pwd=dXo1K25peCtTcjd5U0grUkxxMUNaQT09

9:30 a.m. – 9:35 a.m. Welcome and Introduction, Susan Kaech, Salk
9:35 a.m.– 10:10 a.m. Cosimo Commisso, SBP “Mechanisms of Metabolic Stress Tolerance in Ras-mutant Tumors”
10:10 a.m. – 10:45 a.m. Heather Christofk, UCLA “Targeting Cancer Asparagine Dependence”
10:45 a.m. – 10:55 a.m. Break
10:55 a.m. – 11:05 a.m. Speed talks Round 1
Na Li, UCSD “ALKBH5 Regulates anti–PD-1 Therapy Response by Modulating Lactate and Suppressive Immune Cell Accumulation in Tumor Microenvironment”
Cristina Andreani, University of Cincinnati “FASN Inhibition and Ferroptosis in Mutant KRAS Lung Cancer”
Dilru Silva, University of Utah “Investigating the Mechanisms Governing CDK4/6 Regulated Autophagy in Pancreatic Cancer”
Thekla Cordes, UCSD “Mitochondrial pyruvate metabolism and alanine oxidation influence anchorage-independent cancer cell growth”
11:05 a.m.  – 11:18 a.m. Gabriela Fort, University of Utah “Elucidating mechanisms of resistance to arginine deprivation in MYC-driven small cell lung cancer (SCLC)”
11:18 a.m. – 11:30 a.m. Meredith Frie, Salk “Mutant Zap70 improves T cell activity against tumor neoantigens”
11:30 a.m. – 12:05 p.m. Navdeep Chandel, Northwestern “Mitochondria and Cancer”
12:05 p.m.– 12:45 p.m. Lunch
12:45 p.m. – 1:20 p.m. Donita Brady, University of Pennsylvania “Copper Conducted Kinase Signal Transduction: Mechanisms and Vulnerabilities in Cancer”
1:20 p.m. – 1:55 p.m. Joshua Rabinowitz, Princeton “Energy Sources in Tissues and Tumors”
1:55 p.m. – 2:05 p.m. Break
2:05 p.m. – 2:15 p.m. Speed talks Round 2
Ziyan “Zoe” Xu, Salk “Metabolic and Functional Regulation of Tumor-Associated Macrophages”
Amin Sobh, University of Florida “Adenylate Kinase 2 is a Selective Dependency in NSD2-high Multiple Myeloma”
Caterina Bartolacci, University of Cincinnati “FASN imposes a targetable metabolic dependency on mutant KRAS lung cancer”
Shruti Bhargava, UCSD “Patient-Derived Human Succinate Dehydrogenase-Mutant Gastrointestinal Stromal Tumors Models Identify Novel Drug Vulnerabilities”
2:15 p.m. – 2:27 p.m. Archna Ravi, SBP “PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay”
2:27 p.m. – 2:40 p.m. Michael Trogdon, Salk “Systems modeling of oncogenic mutations in uveal melanoma”
2:40 p.m. – 3:15 p.m. Dafna Bar-Sagi, NYU “Protein Scavenging and Tumor Fitness: A Dynamic Partnership​”
3:15 p.m. – 3:20 p.m. Closing, Reuben Shaw, Salk